Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by James Hardie Industries plc for the month of October 2018, dated October 19, 2018. The registrant is headquartered in Dublin, Ireland, and files annual reports on Form 20-F.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a procedural filing to disclose a change in substantial holding and does not contain a financial results summary.
Material Changes
The primary material change disclosed in this filing is a Change in Substantial Holding, referenced as Exhibit 99.1. No other operational or financial changes are detailed in the provided text.
Guidance, Outlook, and Risks
The filing contains an extensive "Forward-Looking Statements" section cautioning investors against undue reliance on future projections. Key risks and contingencies identified include:
- Asbestos Liabilities: Risks related to prior asbestos product manufacture, contributions to the Asbestos Injuries Compensation Fund (AICF), potential shortfalls in the AICF, and currency exchange impacts on asbestos liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, consumer class action, and intellectual property proceedings.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, consumer confidence, and mortgage availability.
- Operational Risks: Integration of Fermacell, raw material costs, competition, and potential plant closures or capital expenditure projects.
- Financial Risks: Ability to renew credit facilities, tax law changes, and warranty provision adequacy.
Investor Verification Checklist
- Review Exhibit 99.1 (Change in Substantial Holding) to understand the specific ownership change not detailed in the summary text.
- Consult the most recent Form 20-F (filed May 22, 2018) for detailed financial metrics, risk factors, and segment performance.
- Monitor updates regarding the Asbestos Injuries Compensation Fund (AICF) and associated government loan facilities.
- Verify current status of the Fermacell integration and any pending legal proceedings mentioned in the risk factors.